[1]司艳凤,张媛媛,毕凌云.激活蛋白-1在骨代谢相关信号通路中的作用研究进展[J].新乡医学院学报,2023,40(1):097-100.[doi:10.7683/xxyxyxb.2023.01.018]
 SI Yanfeng,ZHANG Yuanyuan,BI Lingyun.Research progress of effect of activator protein-1 in bone metabolism related signaling pathway[J].Journal of Xinxiang Medical University,2023,40(1):097-100.[doi:10.7683/xxyxyxb.2023.01.018]
点击复制

激活蛋白-1在骨代谢相关信号通路中的作用研究进展
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
40卷
期数:
2023年1期
页码:
097-100
栏目:
综述
出版日期:
2023-01-05

文章信息/Info

Title:
Research progress of effect of activator protein-1 in bone metabolism related signaling pathway
作者:
司艳凤张媛媛毕凌云
(新乡医学院第一附属医院儿科,河南 卫辉 453100)
Author(s):
SI YanfengZHANG YuanyuanBI Lingyun
(Department of Pediatrics,the First Affiliated Hospital of Xinxiang Medical University,Weihui 453100,Henan Province,China)
关键词:
激活蛋白-1骨代谢核因子-κB受体活化因子信号通路
Keywords:
activator protein-1bone metabolismreceptor-activator of nuclear factor kappa betasignal pathway
分类号:
R692.3+4
DOI:
10.7683/xxyxyxb.2023.01.018
文献标志码:
A
摘要:
激活蛋白-1(AP-1)是调节细胞增殖、分化和凋亡的关键转录因子。AP-1可通过调控成骨细胞和破骨细胞的增殖、分化和凋亡,参与骨骼生长的生理及病理过程。近年来研究发现,AP-1作为核因子-κB受体活化因子配体/核因子-κB受体活化因子信号通路的重要转录因子,主要通过核因子-κB和Jun氨基末端激酶、细胞外信号调节激酶和p38信号通路调节破骨细胞形成,参与骨代谢过程,其与骨质疏松、骨肿瘤等代谢性骨疾病的发生发展相关,这为代谢性骨疾病提供了新的治疗靶点。本文就AP-1在骨代谢相关信号通路的作用研究进展作一综述。
Abstract:
Activator protein-1 (AP-1) is a key transcription factor that regulates cell proliferation,differentiation and apoptosis.AP-1 can participate in the physiological and pathological process of bone growth by regulating the proliferation,differentiation and apoptosis of osteoblasts and osteoclasts.Recent studies have found that AP-1 as an important transcription factor in nuclear factor kappa beta ligand/receptor-activator of nuclear factor kappa beta signaling pathway,regulates osteoclast formation and participates in bone metabolism mainly through nuclear factor kappa beta and Jun N-terminal kinase,extracellular regulated protein kinases and p38 signaling pathways,and which is related to the occurrence and development of metabolic bone diseases such as osteoporosis and bone tumors,this provides a new therapeutic target for metabolic bone diseases.This article reviews the research progress of AP-1 in bone metabolism related signal pathways.

参考文献/References:

[1] CHANG C Y,ROSENTHAL D I,MITCHELL D M,et al.Imaging findings of metabolic bone disease[J].Radiographics,2016,36(6):1871-1887.
[2] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2017)[J].中国骨质疏松杂志,2019,25(3):281-309.
CHINESE SOCIETY OF OSTEOPOROSIS AND BONE MINERA1 RESEARCH.Guidelines for the diagnosis and management of primary osteoporosis (2017) [J].Chin J Osteoporos,2019,25(3):281-309.
[3] MANKIN H J,MANKIN C J.Metabolic bone disease:a review and update[J].Instr Course Lect,2008,57:575-593.
[4] SHAULIAN E,KARIN M.AP-1 as a regulator of cell life and death[J].Nat Cell Biol,2002,4(5):E131-E136.
[5] NAKASHIMA T,HAYASHI M,TAKAYANAGI H.New insights into osteoclastogenic signaling mechanisms[J].Trends Endocrinol Metab,2012,23(11):582-590.
[6] PARK J H,LEE N K,LEE S Y.Current understanding of RANK signaling in osteoclast differentiation and maturation[J].Mol Cells,2017,40(10):706-713.
[7] KHOSLA S,HOFBAUER L C.Osteoporosis treatment:recent developments and ongoing challenges[J].Lancet Diabetes Endocrinol,2017,5(11):898-907.
[8] LAMBERT S A,JOLMA A,CAMPITELLI L F,et al.The human transcription factors[J].Cell,2018,172(4):650-665.
[9] ATSAVES V,LEVENTAKI V,RASSIDAKIS G Z,et al.AP-1 transcription factors as regulators of immune responses in cancer[J].Cancers (Basel),2019,11(7):1037.
[10] RODRIGUEZ-MARTINEZ J A,REINKE A W,BHIMSARIA D,et al.Combinatorial bZIP dimers display complex DNA-binding specificity landscapes[J].Elife,2017,6(1):e19272.
[11] FAN F,PODAR K.The role of AP-1 transcription factors in plasma cell biology and multiple myeloma pathophysiology[J].Cancers (Basel),2021,13(10):2326.
[12] KALLURU R,PETRIE K J,GREY A,et al.Randomised trial assessing the impact of framing of fracture risk and osteoporosis treatment benefits in patients undergoing bone densitometry[J].BMJ Open,2017,7(2):e13703.
[13] LAM S W,CLEVEN A H G,KROON H M,et al.Utility of FOS as diagnostic marker for osteoid osteoma and osteoblastoma[J].Virchows Arch,2020,476(3):455-463.
[14] EFERL R,WAGNER E F.AP-1:a double-edged sword in tumorigenesis[J].Nat Rev Cancer,2003,3(11):859-868.
[15] BOZEC A,BAKIRI L,JIMENEZ M,et al.Fra-2/AP-1 controls bone formation by regulating osteoblast differentiation and collagen production[J].J Cell Biol,2010,190(6):1093-1106.
[16] WANG N,LIU W,TAN T,et al.Notch signaling negatively regulates BMP9-induced osteogenic differentiation of mesenchymal progenitor cells by inhibiting JunB expression[J].Oncotarget,2017,8(65):109661-109674.
[17] FITTALL M W,MIFSUD W,PILLAY N,et al.Recurrent rearrangements of FOS and FOSB define osteoblastoma[J].Nat Commun,2018,9(1):2150.
[18] FLEISCHMANN A,HAFEZI F,ELLIOTT C,et al.Fra-1 replaces c-Fos-dependent functions in mice[J].Genes Dev,2000,14(21):2695-2700.
[19] WAGNER E F,EFERL R.Fos/AP-1 proteins in bone and the immune system[J].Immunol Rev,2005,208:126-140.
[20] ONO T,HAYASHI M,SASAKI F,et al.RANKL biology:bone metabolism,the immune system,and beyond[J].Inflamm Regen,2020,40:2.
[21] LIU Y,WANG C,WANG,et al.Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities[J].Theranostics,2019,9(16):4648-4662.
[22] FANG Q,ZHOU C,NANDAKUMAR K S.Molecular and cellular pathways contributing to joint damage in rheumatoid arthritis[J].Mediators Inflamm,2020,2020(1):3830212.
[23] CHOI M C,JO J,PARK J,et al.NF-kappaB signaling pathways in osteoarthritic cartilage destruction [J].Cells,2019,8(7):734.
[24] YAO J,WENG Y,YAN S,et al.NOV inhibits proliferation while promoting apoptosis and migration in osteosarcoma cell lines through p38/MAPK and JNK/MAPK pathways[J].Oncol Rep,2015,34(4):2011-2021.
[25] BODE A M,DONG Z.The functional contrariety of JNK[J].Mol Carcinog,2007,46(8):591-598.
[26] LI Y S,DENG Z H,ZENG C,et al.JNK pathway in osteosarcoma:pathogenesis and therapeutics[J].J Recept Signal Transduct Res,2016,36(5):465-470.
[27] DAVID J P,SABAPATHY K,HOFFMANN O,et al.JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms[J].J Cell Sci,2002,115(Pt 22):4317-4325.
[28] KE D,ZHU Y,ZHENG W,et al.Autophagy mediated by JNK1 resists apoptosis through TRAF3 degradation in osteoclastogenesis[J].Biochimie,2019,167:217-227.
[29] WANG F,KE Z F,WANG R,et al.Astrocyte elevated gene-1 (AEG-1) promotes osteosarcoma cell invasion through the JNK/c-Jun/MMP-2 pathway[J].Biochem Biophys Res Commun,2014,452(4):933-939.
[30] KIM B H,OH J H,LEE N K.The Inactivation of ERK1/2,p38 and NF-kB is involved in the down-regulation of osteoclastogenesis and function by A2B adenosine receptor stimulation[J].Mol Cells,2017,40(10):752-760.
[31] CUADRADO A,NEBREDA A R.Mechanisms and functions of p38 MAPK signalling[J].Biochem J,2010,429(3):403-417.
[32] CAVERZASIO J,MANEN D.Essential role of Wnt3a-mediated activation of mitogen-activated protein kinase p38 for the stimulation of alkaline phosphatase activity and matrix mineralization in C3H10T1/2 mesenchymal cells[J].Endocrinology,2007,148(11):5323-5330.
[33] TIAN F,MAURO T M,LI Z.The pathological role of Wnt5a in psoriasis and psoriatic arthritis[J].J Cell Mol Med,2019,23(9):5876-5883.
[34] SUN T,YAN Z,CAI J,et al.Effects of mechanical vibration on cell morphology,proliferation,apoptosis,and cytokine expression/secretion in osteocyte-like MLO-Y4 cells exposed to high glucose[J].Cell Biol Int,2019,Epub ahead of print.
[35] HU H,ZHAO C,ZHANG P,et al.miR-26b modulates OA induced BMSC osteogenesis through regulating GSK3beta/beta-catenin pathway[J].Exp Mol Pathol,2019,107:158-164.
[36] WALSH M C,CHOI Y.Biology of the RANKL-RANK-OPG system in immunity,bone,and beyond [J].Front Immunol,2014,5:511.
[37] IKEBUCHI Y,AOKI S,HONMA M,et al.Coupling of bone resorption and formation by RANKL reverse signalling[J].Nature,2018,561(7722):195-200.
[38] LOCHAB A K,EXTAVOUR C G.Bone morphogenetic protein (BMP) signaling in animal reproductive system development and function[J].Dev Biol,2017,427(2):258-269.
[39] HONG G,HE X,SHEN Y,et al.Chrysosplenetin promotes osteoblastogenesis of bone marrow stromal cells via Wnt/beta-catenin pathway and enhances osteogenesis in estrogen deficiency-induced bone loss[J].Stem Cell Res Ther,2019,10(1):277.
[40] TERPOS E,RAJE N,CROUCHER P,et al.Denosumab compared with zoledronic acid on PFS in multiple myeloma:exploratory results of an international phase 3 study[J].Blood Adv,2021,5(3):725-736.

相似文献/References:

[1]李万里 王 萍 王守英 田玉慧 刘晓丽.钙与鸡冠花提取物对氟中毒大鼠骨代谢的影响[J].新乡医学院学报,1999,16(04):289.
[2]王 雷,刘 华.鹿瓜多肽注射液联合椎体成形术治疗老年骨质疏松性胸腰椎压缩性骨折的疗效及对患者骨代谢的影响[J].新乡医学院学报,2016,33(10):878.[doi:10.7683/xxyxyxb.2016.10.011]
 WANG Lei,LIU Hua.Curative efficacy of cervus&cucumis polypeptide injection combined with vertebroplasty in elderly patients osteoporotic vertebral compression fracture of thoracolumbar spine&bone metabolism effect[J].Journal of Xinxiang Medical University,2016,33(1):878.[doi:10.7683/xxyxyxb.2016.10.011]
[3]鲁世金,孙长英.免疫衰老对骨代谢及骨源性激素分泌的影响研究进展[J].新乡医学院学报,2019,36(9):896.[doi:10.7683/xxyxyxb.2019.09.022]
[4]禹远远,侯卫东,丁红霞,等.丹栀逍遥胶囊联合醋酸曲普瑞林治疗特发性中枢性性早熟女性患儿疗效观察[J].新乡医学院学报,2021,38(11):1048.[doi:10.7683/xxyxyxb.2021.11.009]
 YU Yuanyuan,HOU Weidong,DING Hongxia,et al.Effect of Danzhi Xiaoyao Capsule combined with triptorelin acetate in the treatment of female children with idiopathic central precocious puberty[J].Journal of Xinxiang Medical University,2021,38(1):1048.[doi:10.7683/xxyxyxb.2021.11.009]
[5]乔喜娟,贺孝良.左乙拉西坦和丙戊酸钠对癫痫患儿骨代谢的影响[J].新乡医学院学报,2020,37(9):881.[doi:10.7683/xxyxyxb.2020.09.018]
 QIAO Xijuan,HE Xiaoliang.Effects of levetiracetam and sodium valproate on bone metabolism in children with epilepsy[J].Journal of Xinxiang Medical University,2020,37(1):881.[doi:10.7683/xxyxyxb.2020.09.018]
[6]胡光辉,刘亚峰.唑来膦酸注射液对行髋关节置换术患者骨代谢的影响[J].新乡医学院学报,2023,40(10):960.[doi:10.7683/xxyxyxb.2023.10.010]
 HU Guanghui,LIU Yafeng.Effect of zoledronic acid injection on bone metabolism in patients undergoing hip replacement[J].Journal of Xinxiang Medical University,2023,40(1):960.[doi:10.7683/xxyxyxb.2023.10.010]

更新日期/Last Update: 2023-01-05